Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Erich Rajkovic0
Michael Tesar0
Uwe Reusch0
Martin Treder0
Kristina Ellwanger0
Michael Kluge0
Ivica Fucek0
Michael Damrat0
Date of Patent
September 3, 2024
0Patent Application Number
180479170
Date Filed
October 19, 2022
0Patent Citations
Patent Primary Examiner
Patent abstract
Described are tetravalent, bispecific EGFR/CD16A antigen-binding proteins for engaging NK-cells towards EGFR-positive cells. EGFR/CD16A antigen-binding proteins with different pharmacokinetic (PK) properties are described. Further described is the use of bispecific EGFR/CD16A antigen-binding proteins for the treatment of an EGFR-positive malignancy, such as EGFR-positive tumors.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
